SECUKINUMAB IN GIANT CELL ARTERITIS: THE RANDOMISED, PARALLEL-GROUP, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTRE PHASE 2 TITAIN TRIAL

被引：6
|
作者：
Venhoff, N. [1 ]
Schmidt, W. A. [2 ]
Bergner, R. [3 ]
Rech, J. [4 ]
Unger, L. [5 ]
Tony, H. P. [6 ]
Mendelson, M. [7 ]
Sieder, C. [8 ]
Maricos, M. [8 ]
Thiel, J. [1 ,9 ]
机构：
[1] Univ Freiburg, Vasculitis Ctr Freiburg, Dept Rheumatol & Clin Immunol, Med Ctr, Freiburg, Germany
[2] Med Ctr Rheumatol Berlin Buch, Immanuel Krankenhaus Berlin, Berlin, Germany
[3] Klinikum Stadt Ludwigshafen, Med Klin, Ludwigshafen, Germany
[4] Friedrich Alexander Univ FAU Erlangen Nurnberg, Dept Internal Med Rheumatol & Immunol 3, Erlangen, Germany
[5] Stadt Klinikum Dresden, Med Dept 1, Dresden, Germany
[6] Rheumatol & Clin Immunol Oberduerrbachertstr, Dept Med 2, Wurzburg, Germany
[7] Novartis Pharmaceut, Rheumatol, Newark, NJ USA
[8] Novartis Pharma GmbH, Rheumatol, Nurnberg, Germany
[9] Med Univ Graz, Div Rheumatol & Immunol, Dept Internal Med, Graz, Austria
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.806
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
OP0182
引用
收藏
页码：121 / 122
页数：2
相关论文
共 50 条
  • [31] A randomized, double-blind, parallel-group, placebo-controlled Phase 3 trial to evaluate efficacy and safety of ocrelizumab in PPMS
    Montalban, Xavier
    Hemmer, Bernhard
    Rammohan, Kottil W.
    Giovannoni, Gavin
    De Seze, Jerome
    Bar-Or, Amit
    Arnold, Douglas L.
    Sauter, Annette
    Masterman, Donna
    Fontoura, Paulo
    Chin, Peter
    Garren, Hideki
    Wolinsky, Jerry S.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 17 - 17
  • [32] A multicentre, randomised, double-blind, parallel-group, placebo-controlled trial of apatinib in local progressive or metastatic radioactive iodine-refractory differentiated thyroid cancer
    Lin, Y.
    Qin, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [33] A multicentre, randomised, double-blind, parallel-group, placebo-controlled trial of apatinib in local progressive or metastatic radioactive iodine-refractory differentiated thyroid cancer
    Lin, Y.
    Qin, S.
    ANNALS OF ONCOLOGY, 2017, 28
  • [34] A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis
    Hoffman, GS
    Cid, MC
    Hellman, DB
    Guillevin, L
    Stone, JH
    Schousboe, J
    Cohen, P
    Calabrese, LH
    Dickler, H
    Merkel, PA
    Fortin, P
    Flynn, JA
    Locker, GA
    Easley, KA
    Schned, E
    Hunder, GG
    Sneller, MC
    Tuggle, C
    Swanson, H
    Hernández-Rodríguez, J
    Lopez-Soto, A
    Bork, D
    Hoffman, DB
    Kalunian, K
    Klashman, D
    Wilke, WS
    Scheetz, RJ
    Mandell, BF
    Fessler, BJ
    Kosmorsky, G
    Prayson, R
    Luqmani, RA
    Nuki, G
    McRorie, E
    Sherrer, Y
    Baca, S
    Walsh, B
    Ferland, D
    Soubrier, M
    Choi, HK
    Gross, W
    Segal, AM
    Ludivico, C
    Puechal, X
    ARTHRITIS AND RHEUMATISM, 2002, 46 (05): : 1309 - 1318
  • [35] Gaboxadol in angelman syndrome: A double-blind, parallel-group, randomized placebo-controlled phase 3 study
    Keary, Christopher
    Bird, Lynne M.
    de Wit, Marie-Claire
    Hatti, Shivkumar
    Heimer, Gali
    Heussler, Helen
    Kolevzon, Alexander
    Mathews, Adera
    Ochoa-Lubinoff, Cesar
    Tan, Wen-Hann
    Yan, Ying
    Adams, Maxwell
    EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY, 2023, 47 : 6 - 12
  • [36] Mitoxantrone in progressive multiple sclerosis:: a placebo-controlled, double-blind, randomised, multicentre trial
    Hartung, HP
    Gonsette, R
    König, N
    Kwiecinski, H
    Guseo, A
    Morrissey, SP
    Krapf, H
    Zwingers, T
    LANCET, 2002, 360 (9350): : 2018 - 2025
  • [37] Prophylactic ibuprofen in premature infants:: a multicentre, randomised, double-blind, placebo-controlled trial
    Van Overmeire, B
    Allegaert, K
    Casaer, A
    Debauche, C
    Decaluwé, W
    Jespers, A
    Weyler, J
    Harrewijn, I
    Langhendries, JP
    LANCET, 2004, 364 (9449): : 1945 - 1949
  • [38] The Meteoritics Trial: efficacy of methotrexate after remission-induction with tocilizumab and glucocorticoids in giant cell arteritis—study protocol for a randomized, double-blind, placebo-controlled, parallel-group phase II study
    Lena Kreis
    Christian Dejaco
    Wolfgang Andreas Schmidt
    Robert Németh
    Nils Venhoff
    Valentin Sebastian Schäfer
    Trials, 25
  • [39] ANTISEPTIC MOUTHWASH FOR GONORRHOEA PREVENTION (OMEGA): A RANDOMISED, DOUBLE-BLIND, PARALLEL-GROUP, MULTICENTRE TRIAL
    Chow, E. P. F.
    Williamson, D. A.
    Hocking, J. S.
    Law, M. G.
    Maddaford, K.
    Bradshaw, C. S.
    McNulty, A.
    Templeton, D. J.
    Moore, R.
    Murray, G. L.
    Danielewski, J. A.
    Wigan, R.
    Chen, M. Y.
    Guy, R. J.
    Zhang, L.
    Donovan, B.
    Grulich, A. E.
    Kaldor, J. M.
    Whiley, D. M.
    Cornelisse, V. J.
    Howden, B. P.
    Lewis, D. A.
    Read, T. R. H.
    Fairley, C. K.
    SEXUAL HEALTH, 2020, 17 (05) : VIII - VIII
  • [40] Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a randomised, double-blind, parallel-group, multicentre trial
    Chow, Eric P. F.
    Williamson, Deborah A.
    Hocking, Jane S.
    Law, Matthew G.
    Maddaford, Kate
    Bradshaw, Catriona S.
    McNulty, Anna
    Templeton, David J.
    Moore, Richard
    Murray, Gerald L.
    Danielewski, Jennifer A.
    Wigan, Rebecca
    Chen, Marcus Y.
    Guy, Rebecca J.
    Zhang, Lei
    Donovan, Basil
    Grulich, Andrew E.
    Kaldor, John M.
    Whiley, David M.
    Cornelisse, Vincent J.
    Howden, Benjamin P.
    Lewis, David A.
    Read, Tim R. H.
    Fairley, Christopher K.
    LANCET INFECTIOUS DISEASES, 2021, 21 (05): : 647 - 656
12345